doi: 10.1038/s41591-025-03858-6, 86 LarsenP
Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial
Quantification of semaglutide distribution and action in mouse brain regions associated with reward and food intake
The April 2024 landmark paper proposing BPC-157 as a cytoprotection mediator with neurotransmitter-like activity provides an elegant theoretical framework, but elegance is not evidence
The meds increase our natural supply of GLP-1, amplifying its impact across multiple regions of the gut and the brain, and possibly also reducing systemic inflammation
Key Takeaways Semaglutide can start to show effects within the first week, with noticeable weight loss often seen within 4 to 5 months